382 related articles for article (PubMed ID: 8093577)
1. Three types of akinesia in the progressive course of Parkinson's disease.
Narabayashi H
Adv Neurol; 1993; 60():18-24. PubMed ID: 8093577
[No Abstract] [Full Text] [Related]
2. Chairman's introduction: role of the pallidum and its transmitters in the therapy of parkinsonian rigidity and akinesia.
Hassler RG
Adv Neurol; 1984; 40():1-14. PubMed ID: 6141708
[No Abstract] [Full Text] [Related]
3. Problems arising during chronic treatment with L-dopa for Parkinson's disease: changes in response to treatment.
Caraceni TA; Girotti F; Giovannini P; Parati E
J Neural Transm Suppl; 1986; 22():189-99. PubMed ID: 3537210
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?
Agid Y; Graybiel AM; Ruberg M; Hirsch E; Blin J; Dubois B; Javoy-Agid F
Adv Neurol; 1990; 53():83-100. PubMed ID: 1978522
[No Abstract] [Full Text] [Related]
5. Movement disorders stereotactic surgery for Parkinson's disease.
Iacono RP; Lonser R; Morenski JD
Mov Disord; 1994 Jul; 9(4):470-2. PubMed ID: 7848465
[No Abstract] [Full Text] [Related]
6. Clinical features, diagnosis, and imaging of parkinsonian syndromes.
Poewe W
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):333-8. PubMed ID: 8507902
[TBL] [Abstract][Full Text] [Related]
7. Dynamic aspects of the striatothalamic connection studied in cases with movement disorder.
Ohye C
Adv Neurol; 1993; 60():78-83. PubMed ID: 8420220
[No Abstract] [Full Text] [Related]
8. The role of the medial pallidum in the pathophysiology of akinesia in primates.
Percheron G; Filion M; Tremblay L; Fénelon G; François C; Yelnik J
Adv Neurol; 1993; 60():84-7. PubMed ID: 8420221
[No Abstract] [Full Text] [Related]
9. [Mechanism of the development of akinesia in Parkinson's disease --with reference to L-threo-DOPS therapy].
Narabayashi H
No To Shinkei; 1983 Nov; 35(11):1057-63. PubMed ID: 6362685
[No Abstract] [Full Text] [Related]
10. Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness.
Hornykiewicz O
Neurodegener Dis; 2008; 5(3-4):114-7. PubMed ID: 18322366
[TBL] [Abstract][Full Text] [Related]
11. Interactions of exogenous L-dopa with nigrostriatal dopaminergic neurons in Parkinson's disease.
Melamed E
Adv Neurol; 1990; 53():61-6. PubMed ID: 2173376
[No Abstract] [Full Text] [Related]
12. Biochemical aspects of Parkinson's disease.
Nagatsu T
Adv Neurol; 1993; 60():165-74. PubMed ID: 8093575
[No Abstract] [Full Text] [Related]
13. Pathophysiology of motor response complications in Parkinson's disease: hypotheses on the why, where, and what.
Metman LV; Konitsiotis S; Chase TN
Mov Disord; 2000 Jan; 15(1):3-8. PubMed ID: 10634235
[No Abstract] [Full Text] [Related]
14. Pathophysiology of parkinsonian motor abnormalities.
Wichmann T; DeLong MR
Adv Neurol; 1993; 60():53-61. PubMed ID: 8420185
[No Abstract] [Full Text] [Related]
15. Striatal molecular mechanisms and motor dysfunction in Parkinson's disease.
Chase TN; Konitsiotis S; Oh JD
Adv Neurol; 2001; 86():355-60. PubMed ID: 11553996
[No Abstract] [Full Text] [Related]
16. [Movement disorders and basal ganglia function].
Dietrichs E
Tidsskr Nor Laegeforen; 2008 Sep; 128(17):1968-71. PubMed ID: 18787574
[TBL] [Abstract][Full Text] [Related]
17. Disturbances in higher function in Parkinson's disease.
Tamaru F
Eur Neurol; 1997; 38 Suppl 2():33-6. PubMed ID: 9387801
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of dopaminergic agents in Parkinson's disease.
Koller WC; Rueda MG
Neurology; 1998 Jun; 50(6 Suppl 6):S11-4; discussion S44-8. PubMed ID: 9633680
[TBL] [Abstract][Full Text] [Related]
19. Molecular neuroanatomic mechanisms of Parkinson's disease: a proposed therapeutic approach.
Gerfen CR; Engber TM
Neurol Clin; 1992 May; 10(2):435-49. PubMed ID: 1350051
[TBL] [Abstract][Full Text] [Related]
20. New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable.
Hadj Tahar A; Grondin R; Grégoire L; Calon F; Di Paolo T; Bédard PJ
Adv Neurol; 2003; 91():51-64. PubMed ID: 12442663
[No Abstract] [Full Text] [Related]
[Next] [New Search]
